← Back to headlines
FDA Considers Easing Peptide Restrictions Amid RFK Jr.'s Advocacy, Experts Warn of Risks
Shares of Hims & Hers surged after the FDA initiated a review of restricted peptide compounds. The FDA is reportedly set to discuss easing these restrictions at an anticipated July meeting, a move influenced by RFK Jr.'s advocacy for greater accessibility, though experts caution about potential risks.
16 Apr, 17:12 — 16 Apr, 21:48
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
Yahoo
Center
Right
Far R1
Far Right (1)
Fox News
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
Fox NewsMixed1h ago
Peptides may soon be easier to get amid RFK Jr.'s push, but experts warn of risks
The FDA is reportedly set to discuss easing peptide restrictions at an anticipated July meeting, as RFK Jr. advocates for making the treatments more accessible.
Read full article →YahooMostly Factual6h ago
Hims & Hers shares jump as FDA begins review of restricted peptide compounds
Read full article →Coverage Timeline
First report: Yahoo · 16 Apr, 17:12|Full coverage: 2 · 5h|Window: 5h
Left-leaningCenterRight-leaning
